Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

FTLF earnings analysis

Filed August 13, 2026 · Our reading of the company's report

The latest report

The supplied excerpt does not include the current-quarter income statement, balance sheet, cash-flow statement, segment results, or MD&A, so revenue, margin, EPS, cash flow, working-capital, and year-over-year trend…

Read full summary

The supplied excerpt does not include the current-quarter income statement, balance sheet, cash-flow statement, segment results, or MD&A, so revenue, margin, EPS, cash flow, working-capital, and year-over-year trend analysis cannot be determined. The principal disclosed exposures are $36,055 of Irwin Term Loan borrowings, $2,000 of Credit Line borrowings, and unhedged foreign-currency exposure after the 2023 MRC acquisition. No quantitative guidance is provided, and management reports no material changes to the risk factors from the Form 10-K.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

46% Gross margin Operating margin Oct 2022 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Oct 2022 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Partial interest-rate protection

    The company had $36,055 outstanding under the Irwin Term Loan, with $17,750 swapped to a fixed rate, reducing interest-rate variability on that portion. Credit Line borrowings were $2,000 as of June 30, 2026.

What to watch

  • Debt and interest-rate exposure

    The company had $36,055 outstanding under the Irwin Term Loan and $2,000 under its Credit Line as of June 30, 2026. Borrowings under the Credit Agreement expose results to interest-rate changes, although $17,750 of the term loan was fixed through a swap.

  • Unhedged foreign-currency exposure

    Following the 2023 MRC acquisition, the company has increased foreign-currency exposure. It entered into zero foreign-currency hedging transactions during the three months ended June 30, 2026, leaving results exposed to exchange-rate movements and foreign-market conditions.

  • No updated risk-factor disclosure

    The filing states that management is not aware of any material changes to the risk factors in the Form 10-K for the year ended December 31, 2025, filed June 30, 2026. Consequently, no new quantified risk-factor update is disclosed in the supplied 10-Q text.

Management's outlook

No quantitative revenue or EPS outlook is provided in the supplied 10-Q text. The filing states that management is not aware of any material changes to the risk factors in the Form 10-K filed June 30, 2026.

Earlier filings 4

10-Q · May 14, 2026

FitLife Brands, Inc. reported Q1 2026 earnings with significant improvements in revenue and gross profit primarily due to the acquisition of Irwin Naturals, though net income reflects a decline year-over-year. While…

10-K · April 21, 2026

FitLife Brands’ 10-K/A (filed Apr 21, 2026) shows a H2 2025 revenue pickup (Q3 $23.0M, Q4 $26.0M) after lower early-2025 quarters, but cash-flow volatility with a $39.0M negative free cash flow in 2025Q3 and recovery to…

10-K · March 31, 2026

FitLife grew revenue 26% year-over-year to $81.458 million in 2025, driven primarily by the August 8, 2025 acquisition of Irwin (purchase price $42.5 million). However, gross margin compressed to 38.6% (from 43.6% in…

10-Q · November 13, 2025

FitLife reported Q3 revenue of $23.485M (vs. $15.977M a year earlier), driven largely by the August 2025 Irwin acquisition which contributed $6.821M in the quarter. Gross margin compressed to 37.2% and diluted EPS fell…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.